Thesis
Global life sciences VC backing early-stage biotech with breakthrough science and growth-stage healthcare across US and China.
Stages
GrowthSeedSeries ASeries BSeries C
Sectors
BiotechHealthcare/MedtechLife SciencesDeep Tech/Hard Science
Fund
- Current fund
- Decheng Capital Global Life Sciences Fund V · 2024 · $$700M target ($452M raised as of latest filing)
- AUM
- $$2.5B+
- Check size
- $100K – $5M
